US Patent Issued to EVOTECH INTERNATIONAL, RECURSION PHARMACEUTICALS on Jan. 27 for "Pyrazolopyrimidine compounds as adenosine receptor antagonists" (British, French Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,356, issued on Jan. 27, was assigned to EVOTECH INTERNATIONAL GMBH (Hamburg, Germany) and RECURSION PHARMACEUTICALS INC. (Salt Lake City).

"Pyrazolopyrimidine compounds as adenosine receptor antagonists" was invented by Andrew Simon Bell (Dundee, Great Britain), Adrian Michael Schreyer (Dundee, Great Britain) and Stephanie Versluys (Toulouse, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, wherein R1 is an optionally substituted phenyl, or an optionally substit...